Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 12Peripheral Blood Stem Cell Transplantation 10fludarabine phosphate 7Cyclosporine 7Mycophenolic Acid 6Busulfan 6Methotrexate 5Melphalan 4Idarubicin 4Filgrastim 4Etoposide 4Clofarabine 4aldesleukin 3Whole-Body Irradiation 3Tacrolimus 3Radiotherapy 3Mitoxantrone 3Flow Cytometry 3Daunorubicin 3Cyclophosphamide 3Antilymphocyte Serum 3Transplantation 2Radiotherapy, Intensity-Modulated 2Interleukin-2 2Granulocyte Colony-Stimulating Factor 2Cytogenetic Analysis 2Bortezomib 2Alemtuzumab 2tipifarnib 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Congenital Abnormalities × Staining and Labeling × Clear all
NCT00052520 2017-03-29

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Fred Hutchinson Cancer Center

Phase 1/2 Completed
37 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡